公告 Post-effective Amendment to an automatic shelf registration statement

发表于 2024-04-04 06:01   271次浏览

公告 Securities to be offered to employees in employee benefit plans, post-effective

发表于 2024-04-04 05:56   269次浏览

公告 Securities to be offered to employees in employee benefit plans, post-effective

发表于 2024-04-04 05:56   261次浏览

公告 Securities to be offered to employees in employee benefit plans, post-effective

发表于 2024-04-04 05:49   274次浏览

公告 Notification filed by national security exchange to report the removal from lis

发表于 2024-04-03 22:32   260次浏览

公告 Current report, items 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, and 9.01

发表于 2024-04-03 21:57   250次浏览

公告 [Amend] Solicitation, recommendation statements

发表于 2024-04-03 21:53   254次浏览

公告 [Amend] Tender offer statement by Third Party

发表于 2024-04-03 21:23   256次浏览

公告 Annual report [Section 13 and 15(d), not S-K Item 405]

发表于 2024-03-29 05:52   225次浏览

公告 [Amend] Solicitation, recommendation statements

发表于 2024-03-23 05:37   223次浏览

公告 [Amend] Tender offer statement by Third Party

发表于 2024-03-20 05:46   207次浏览

公告 [Amend] Solicitation, recommendation statements

发表于 2024-03-20 05:38   218次浏览

公告 Kinnate Biopharma Inc|Contract Adjustment

发表于 2024-03-20 00:00   125次浏览

公告 Kinnate Biopharma Inc|Contract Adjustment

发表于 2024-03-19 00:00   92次浏览

公告 Statement of changes in beneficial ownership of securities

发表于 2024-03-06 09:07   267次浏览

公告 Statement of changes in beneficial ownership of securities

发表于 2024-03-06 08:53   261次浏览

公告 Statement of changes in beneficial ownership of securities

发表于 2024-03-06 08:38   275次浏览

公告 Tender offer statement by Third Party

发表于 2024-03-05 10:47   271次浏览

公告 Solicitation, recommendation statements

发表于 2024-03-05 08:01   284次浏览

公告 Written communication relating to third party tender offer

发表于 2024-03-01 22:20   324次浏览